Magdalena Czach

Magdalena Czach

Auto-generated profile, based on publicly available information

Magdalena Czach

LUX MED, Postępu 21C, 02-676 Warsaw, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MDMonika Kienanh Do
Monika Kienanh Do
KKKarolina Kazimierska
Karolina Kazimierska
DZDominika Zaliwska
Dominika Zaliwska
AKAdrianna Kraszkiewicz
Adrianna Kraszkiewicz
NPNatalia Paduszyńska
Natalia Paduszyńska
MCMagdalena Czach
Magdalena Czach
Hair graying, or canities, is a complex biological process characterized by the progressive loss of hair pigment, often leading to aesthetic and psychological concerns. This review delves into the multifactorial nature of hair graying, examining the underlying biochemical and physiological mechanisms. Key contributors include oxidative stress, genetic and environmental factors, and disturbances in melanogenesis and signaling pathways such as Notch and Kit. Our extensive literature review from PubMed, involving 33 scientifically rigorous papers, explores the efficiency of various strategies aimed at delaying or preventing hair graying. We highlight the roles of antioxidants, lifestyle modifications, and advanced therapeutic approaches like genetic therapy and liposome delivery systems. Additionally, we explore the impact of diet and UV protection, among other factors, on maintaining hair pigmentation. This review underscores the intricate interplay of biochemical processes in hair graying and sheds light on promising interventions for managing this natural yet often unwelcome sign of aging.

16 July 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MGMarta Justyna Gonciarz
Marta Justyna Gonciarz
DADominika Karolina Adamiec
Dominika Karolina Adamiec
ADAnna Dąbrowska
Anna Dąbrowska
NPNatalia Paduszyńska
Natalia Paduszyńska
DZDominika Zaliwska
Dominika Zaliwska
MDMonika Kienanh Do
Monika Kienanh Do
Introduction and purpose Intermittent fasting (IF) is a dietary pattern that alternates between periods of fasting or reduced caloric intake and periods of unrestricted eating. There are three primary types of IF: Alternate Day Fasting (ADF), Time-Restricted Eating (TRE), and Periodic Fasting (PF). This review article summarizes the impact of IF on weight loss. Additionally, it examines the broader health effects of IF, including its influence on cardiovascular risk, diabetes management, and neurodegenerative diseases. Description of the state of knowledge Fasting, the practice of abstaining from or limiting food intake for a specified period, has been a cultural and religious tradition worldwide for centurie. Common IF methods alternating 24-hour periods of fasting with days of eating, TRE restricts eating to specific windows of time each day, and PF includes patterns such as the 5:2 diet, where fasting occurs on two days each week. Conclusions The analysis of the review article demonstrates that intermittent fasting (IF) leads to weight loss, aiding in the treatment of obesity. Moreover, IF reduces glycated hemoglobin levels and increases periods of normoglycemia, potentially benefiting diabetes patients. Nonetheless, there is a lack of sufficient research to confirm the safety of IF for diabetics, given the risk of hypoglycemia. Research also indicates that IF positively impacts cardiovascular risk factors by lowering total cholesterol, LDL-C, and triglyceride levels. Additionally, while IF might reduce the risk of certain cancers by addressing obesity, it is not advised for cancer patients due to inadequate scientific evidence. Furthermore, some studies indicate that IF could be advantageous in managing certain neurological diseases.

3 June 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
ZCZuzanna Czach
Zuzanna Czach
MCMagdalena Czach
Magdalena Czach
DBDominika Bachurska
Dominika Bachurska
WKWojciech Kopacz
Wojciech Kopacz
ŁMŁukasz Mazurek
Łukasz Mazurek
JOJoanna Olędzka
Joanna Olędzka
This narrative review examines current and emerging treatment strategies for diabetic macular edema (DME), a complication of diabetic retinopathy characterised by fluid accumulation in the macula, which can lead to vision impairment. The incidence of DME is particularly high in patients with long-standing diabetes and advanced retinopathy. The current treatment options for DME include anti-vascular endothelial growth factor (anti-VEGF) agents, corticosteroids, and laser therapies. Anti-VEGF agents, including bevacizumab, ranibizumab, aflibercept, and the more recently developed brolucizumab and faricimab, have been demonstrated to reduce macular thickness and improve visual acuity. Brolucizumab offers the advantage of fewer injections due to its longer duration of action, although it carries a higher risk of ocular inflammation compared to other anti-VEGF agents. The dual inhibition of the VEGF and angiopoietin-2 (Ang-2) pathways by faricimab may enhance vascular stability and reduce inflammation, potentially improving patient outcomes. Steroid therapies, including dexamethasone, fluocinolone acetonide, and triamcinolone acetonide, represent an alternative for patients who do not respond adequately to anti-VEGF treatment. Laser therapies, including focal, navigated, and subthreshold laser treatments, remain a crucial component in the management of DME, with the ability to seal leaking vessels and reduce fluid accumulation. In order to achieve the best outcomes for patients, it is essential to continue to advance these treatment modalities and adopt a personalised, multifaceted approach.

18 September 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MDMonika Kienanh Do
Monika Kienanh Do
MVMarcin Mikusek-Pham Van
Marcin Mikusek-Pham Van
DZDominika Zaliwska
Dominika Zaliwska
AKAdrianna Kraszkiewicz
Adrianna Kraszkiewicz
NPNatalia Paduszyńska
Natalia Paduszyńska
MCMagdalena Czach
Magdalena Czach
Introduction and Aim of the Study: Scarring is a major concern in clinical dermatology, affecting individuals' quality of life due to both physical and psychological impacts. This review aims to explore the pathophysiology of various scar types—hypertrophic, keloid, and atrophic—and evaluate the effectiveness of current and emerging treatments to inform better clinical practices and therapeutic strategies. Description of the State of Knowledge: Scar formation involves complex biological processes: inflammation, proliferation, and remodeling. The nature of the scar varies with the underlying cause and biological response, influenced by genetic factors, skin tension, and environmental elements such as UV exposure. Recent advances in treatments range from surgical techniques to laser therapy and biological agents like cytokines. Conclusion: The studies reviewed underscore the complexity of scar management, influenced by diverse genetic, biological, and environmental factors. No single treatment is universally effective, but a combination of preventative and therapeutic strategies shows the best promise.

16 July 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
AKAdrianna Kraszkiewicz
Adrianna Kraszkiewicz
DZDominika Zaliwska
Dominika Zaliwska
NPNatalia Paduszyńska
Natalia Paduszyńska
ADAnna Dąbrowska
Anna Dąbrowska
MGMarta Justyna Gonciarz
Marta Justyna Gonciarz
MDMonika Kienanh Do
Monika Kienanh Do
Introduction and purpose Obesity is a serious health problem nowadays and it is becoming more and more common. There are plenty of causes of obesity including bad eating habits, genetic factors, and psychological factors. A lot of obese people look for a way to lose weight. Fad diets are popular dietary strategies which are promoted as a quick way to lose weight. This article highlights some popular dietary strategies including low-carbohydrate diet, low-fat diet, Paleolithic Diet and Detox Diet. The aim of this paper is to analyse their effectiveness in the process of successful weight loss and their health impact. State of knowledge According to WHO in 2022 1 in 8 people in the world were obese. Fad diets are promoted as methods to improve health and as a quick way to lose weight. However, available research suggests a rather unfavorable impact on human health in the context of long-term adherence to these diets. Limited data suggests the beneficial long-term health impact of such diets. Moreover, dieting and weight cycling caused by the repetitive process of weight loss after dieting and weight regain afterwards may also play a role in the development of obesity. Conclusion Fad diets are not recommended as a long-term way of nutrition. The main limitation of these dietary strategies is their short-term effectiveness rather than long-term. Adherence to these diets is hard for patients. Because of their strict rules and food exclusions, the risk of weight regain is high. Moreover, they do not show many positive long-term health consequences and they are not superior to conventional healthy diets. What’s more, strict obedience to fad diets for extended periods of time may be detrimental to the dieter's health.

16 July 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
DZDominika Zaliwska
Dominika Zaliwska
AKAdrianna Kraszkiewicz
Adrianna Kraszkiewicz
MDMonika Kienanh Do
Monika Kienanh Do
NPNatalia Paduszyńska
Natalia Paduszyńska
MGMarta Justyna Gonciarz
Marta Justyna Gonciarz
MCMagdalena Czach
Magdalena Czach
Introduction and aim of the study: The growing awareness of gluten-related disorders has led to widespread misinformation about the gluten-free diet(GFD). The potential benefits of removing gluten are not well evaluated, yet it is often recommended or self-implemented by patients without robust supporting evidence. This paper aims to determine whether eliminating gluten from the diet provides proven benefits for individuals with specific diseases, including autoimmune thyroiditis (AIT), type 1 diabetes (T1D), psoriasis, and metabolic syndrome, who do not have a diagnosed gluten-related disorder. Description of the state of knowledge: Adhering to a gluten-free diet may benefit patients with AIT and T1D even without celiac disease, although there is no clear evidence that it alleviates AIT or T1D symptoms and the improvements are not significant enough to recommend it universally. Further research on humans is needed to explore the potential preventive effect of GFD on T1D risk and prolonging partial remission. For psoriasis, a GFD can be beneficial for patients with gluten-related antibodies, potentially reducing or clearing skin lesions, but it shows no benefit for those without these antibodies. The data on the GFD's impact on cardiovascular disease remains contradictory and unreliable. Conclusion: For psoriasis patients who test positive for gluten-related antibodies, a gluten-free diet can be recommended. Current studies do not substantiate the necessity for patients with AIT, T1D or metabolic syndrome to completely eliminate gluten from their diet.